The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness, coordination, ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

Lysosomes are the recycling centers of human cells. Larger molecules are broken down inside the membrane-enclosed vesicles. Malfunctions can lead to neurodegenerative diseases such as Parkinson's.

It’s improving quality of life. Parkinson’s drugs are meant to keep patients in what’s called their “on state,” providing improvement in coordination and stiffness. But as the drugs wear off between ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Subscribe to our ...

Korean researchers say this common bacterium's journey throughout the body could lead to consequences in the brain.

How well our brain functions depends heavily on the performance of our nerve cells. That is why they are regularly checked for their proper function -- defective cell components are marked, disposed ...

Learn to manage anxiety in advanced Parkinson's with treatments like therapy, medication, lifestyle changes, and more to ...

A medication developed in the 1950s to treat Parkinson's disease may offer a powerful new tool in the fight against tuberculosis (TB), according to new research from the University of British Columbia ...

Researchers decipher the function of an ion channel involved in cellular degradation processes and create new possibilities for Parkinson’s therapies.